CIT Inc Revenue Y/Y
What is the Revenue Y/Y of CIT Inc?
The Revenue Y/Y of CIT Group Inc is 80.26%
What is the definition of Revenue Y/Y?
Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.
= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenue Y/Y of companies in the Finance sector on NYSE compared to CIT Inc
What does CIT Inc do?
CIT is a leading national bank focused on empowering businesses and personal savers with the financial agility to navigate their goals. CIT Group Inc. (NYSE: CIT) is a financial holding company with over a century of experience and operates a principal bank subsidiary, CIT Bank, N.A. (Member FDIC, Equal Housing Lender). CIT's commercial banking segment includes commercial financing, community association banking, middle market banking, equipment and vendor financing, factoring, railcar financing, treasury and payments services, and capital markets and asset management. CIT's consumer banking segment includes a national direct bank and regional branch network.
Companies with revenue y/y similar to CIT Inc
- China Resources Medical has Revenue Y/Y of 79.83%
- Kabra Extrusiontechnik has Revenue Y/Y of 79.97%
- Agile Therapeutics Inc has Revenue Y/Y of 79.99%
- MBH PLC has Revenue Y/Y of 80.07%
- CIT has Revenue Y/Y of 80.14%
- Matrix Composites & Engineering Ltd has Revenue Y/Y of 80.17%
- CIT Inc has Revenue Y/Y of 80.26%
- BCI Minerals has Revenue Y/Y of 80.52%
- Sprague Resources LP has Revenue Y/Y of 80.55%
- UroGen Pharma has Revenue Y/Y of 80.61%
- Solar Industries India has Revenue Y/Y of 80.88%
- CytomX Therapeutics Inc has Revenue Y/Y of 80.93%
- Capital Product Partners L P has Revenue Y/Y of 81.04%